US 11655241
Heterocyclic compound and use thereof
granted A61KA61K31/40A61K31/4025
Quick answer
US patent 11655241 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/40, A61K31/4025, A61K31/427, A61K31/4439